Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial.

Sean J. Mulvihill,Robert S. Warren,Alan P. Venook,A. Adler,Britta Randlev,Carla Heise,David Kirn

Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial.

2001

Sean J. Mulvihill
Robert S. Warren
Alan P. Venook
A. Adler
Britta Randlev
Carla Heise
David Kirn

Safety and feasibility of injection with an E1B-55 kDa gene-deleted, replication-selective adenovirus (ONYX-015) into primary carcinomas of the pancreas: a phase I trial

Keywords:

Carcinoma
Molecular biology
Gene
Adenoviridae
Genetic enhancement
Pancreas
Biology
Cancer
Pathology
Tumor progression
Pancreatitis
gene mutation
cellular immunity
Cancer research
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

252

Citations